Show simple item record

dc.contributor.authorvan der Colf, Berta E.
dc.contributor.authorvan Zyl, Gert U.
dc.contributor.authorNoden, Bruce H.
dc.contributor.authorNtirampeba, Dismas
dc.date.accessioned2022-04-12T13:30:00Z
dc.date.available2022-04-12T13:30:00Z
dc.date.issued2020-05-13
dc.identifieroksd_noden_seroprevalenceoftoxoplasmagondii_2020
dc.identifier.citationvan der Colf, B. E., van Zyl, G. U., Noden, B. H., & Ntirampeba, D. (2020). Seroprevalence of Toxoplasma gondii infection among pregnant women in Windhoek, Namibia, in 2016. Southern African Journal of Infectious Diseases, 35(1), Article 25. https://doi.org/10.4102/sajid.v35i1.25
dc.identifier.urihttps://hdl.handle.net/11244/335136
dc.description.abstractBackground: When a pregnant woman contracts Toxoplasma gondii (T. gondii) infection during pregnancy, it may be vertically transmitted to the foetus. Information on the incidence of congenital toxoplasmosis (CT) in developing countries is scarce. Most studies focus on the seroprevalence of T. gondii infection among pregnant women. This study aimed to determine the seroprevalence of T. gondii infection among pregnant women attending public antenatal care in Windhoek, Namibia, in 2016.
dc.description.abstractMethods: In this descriptive study, 344 urban pregnant women attending public antenatal care were voluntarily enrolled in the study. Seroprevalence of anti-T. gondii Immunoglobulin G (IgG) was determined by automated immunoassay. Samples with a positive T. gondii IgG result were tested for T. gondii Immunoglobulin M (IgM) and specific IgG avidity by using an enzyme-linked immunosorbent assay (ELISA) test. A questionnaire captured demographic data and exposure to risk factors. Data were analysed using Statistical Package for the Social Sciences (SPSS) and R.
dc.description.abstractResults: Anti-T. gondii IgG was found in nine (2.61%) pregnant women. There was no association of anti-T. gondii IgG with demographic characteristics or exposure to risk factors. Anti-T. gondii IgM was positive in one (0.3%) woman, while three (0.9%) women had borderline anti-T. gondii IgM results. Specific IgG avidity was low, equivocal and high in 0%, 33% and 67% of seropositive pregnant women, respectively.
dc.description.abstractConclusion: Seroprevalence of anti-T. gondii IgG is much lower in Namibia than is reported in other developing countries. Investigation into specific IgM seropositivity and IgG avidity showed that pregnant women in the central region of Namibia are at low risk of vertical transmission and development of CT.
dc.formatapplication/pdf
dc.languageen_US
dc.publisherAOSIS
dc.relation.ispartofSouthern African Journal of Infectious Diseases, 35 (1)
dc.relation.urihttps://www.ncbi.nlm.nih.gov/pubmed/34485464
dc.rightsThis material has been previously published. In the Oklahoma State University Library's institutional repository this version is made available through the open access principles and the terms of agreement/consent between the author(s) and the publisher. The permission policy on the use, reproduction or distribution of the material falls under fair use for educational, scholarship, and research purposes. Contact Digital Resources and Discovery Services at lib-dls@okstate.edu or 405-744-9161 for further information.
dc.titleSeroprevalence of Toxoplasma gondii infection among pregnant women in Windhoek, Namibia, in 2016
dc.date.updated2022-04-07T14:10:11Z
osu.filenameoksd_noden_seroprevalenceoftoxoplasmagondii_2020.pdf
dc.description.peerreviewPeer reviewed
dc.identifier.doi10.4102/sajid.v35i1.25
dc.description.departmentEntomology and Plant Pathology
dc.type.genreArticle
dc.type.materialText
dc.subject.keywordsIgG avidity
dc.subject.keywordsNamibia
dc.subject.keywordsToxoplasma gondii
dc.subject.keywordspregnant women
dc.subject.keywordsseroprevalence
dc.subject.keywordstoxoplasmosis
dc.subject.keywordsEmerging Infectious Diseases
dc.subject.keywordsPerinatal Period - Conditions Originating in Perinatal Period
dc.subject.keywordsPrevention
dc.subject.keywordsFoodborne Illness
dc.subject.keywordsInfectious Diseases
dc.subject.keywordsVaccine Related
dc.subject.keywordsPediatric
dc.subject.keywordsBiodefense
dc.subject.keywordsInfection
dc.subject.keywordsReproductive health and childbirth
dc.identifier.authorORCID: 0000-0002-7159-5609 (van der Colf, Berta E.rta E)
dc.identifier.authorORCID: 0000-0003-3021-5101 (van Zyl, Gert U)
dc.identifier.authorORCID: 0000-0002-0096-370X (Noden, Bruce H)
dc.identifier.authorScopusID: 6601968347 (Noden, Bruce H)
dc.identifier.authorORCID: 0000-0002-6278-8134 (Ntirampeba, Dismas)


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record